Join Our FREE On-Demand Webinar!

The Journey to Generic Oncology

As more oncology therapies transition from innovative medicines to widely available generic treatments, analytical laboratories play a critical role in ensuring these medicines remain safe, effective and accessible to patients. This webinar highlights a range of oncology applications, including olaparib, sorafenib, imatinib, ibrutinib, and the combination of palbociclib and letrozole, demonstrating how modern HPLC methods and alternative column technologies can support assay and impurity analysis while meeting compendial and quality requirements. Attendees will gain practical insights into method modernisation, column selection and analytical strategies that help manufacturers efficiently bring high-quality generic oncology medicines to market.
I would like to receive personalized information about products and services from Phenomenex and other Danaher group companies as indicated below. I understand that my preferences and interactions, including whether I’ve opened your messages, will be used to personalize content to my interests.